{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:27:28Z","timestamp":1787099248011,"version":"build-2736575974"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK102619"],"award-info":[{"award-number":["R01DK102619"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL177566"],"award-info":[{"award-number":["R01HL177566"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-75425-7","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:26:20Z","timestamp":1783923980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic or pharmacological inhibition of hepatic TMEM141 attenuates MASH and fibrosis via the ROS-HNF4\u03b1 signaling pathway"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9697-2004","authenticated-orcid":false,"given":"Jiayou","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chwen-Lih","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Gopoju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid","family":"Batayneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5511-8215","authenticated-orcid":false,"given":"Yeong-Renn","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4753-7326","authenticated-orcid":false,"given":"Jeffrey","family":"Mellott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshitha","family":"Gunawardana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1886-7775","authenticated-orcid":false,"given":"Yanqiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"75425_CR1","doi-asserted-by":"crossref","unstructured":"Reid, M. V., Fredickson, G. & Mashek, D. G. Mechanisms coupling lipid droplets to MASLD pathophysiology. Hepatology 84, 273\u2013291 (2024).","DOI":"10.1097\/HEP.0000000000001141"},{"key":"75425_CR2","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78, 1966\u20131986 (2023).","journal-title":"Hepatology"},{"key":"75425_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77, 1335\u20131347 (2023).","journal-title":"Hepatology"},{"key":"75425_CR4","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.tem.2014.08.001","volume":"25","author":"CD Fuchs","year":"2014","unstructured":"Fuchs, C. D., Claudel, T. & Trauner, M. Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD. Trends Endocrinol. Metab. 25, 576\u2013585 (2014).","journal-title":"Trends Endocrinol. Metab."},{"key":"75425_CR5","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1002\/hep.28472","volume":"63","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice. Hepatology 63, 1860\u20131874 (2016).","journal-title":"Hepatology"},{"key":"75425_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/srep24277","volume":"6","author":"J Xu","year":"2016","unstructured":"Xu, J. et al. Carboxylesterase 1 is regulated by hepatocyte nuclear factor 4alpha and protects against alcohol- and MCD diet-induced liver injury. Sci. Rep. 6, 24277 (2016).","journal-title":"Sci. Rep."},{"key":"75425_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11154-020-09568-3","volume":"21","author":"JL Merritt 2nd","year":"2020","unstructured":"Merritt, J. L. 2nd, MacLeod, E., Jurecka, A. & Hainline, B. Clinical manifestations and management of fatty acid oxidation disorders. Rev. Endocr. Metab. Disord. 21, 479\u2013493 (2020).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"75425_CR8","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1124\/pharmrev.124.000978","volume":"76","author":"T Li","year":"2024","unstructured":"Li, T. & Chiang, J. Y. L. Bile acid signaling in metabolic and inflammatory diseases and drug development. Pharm. Rev. 76, 1221\u20131253 (2024).","journal-title":"Pharm. Rev."},{"key":"75425_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2024.100527","volume":"65","author":"R Gopoju","year":"2024","unstructured":"Gopoju, R. et al. Hepatic FOXA3 overexpression prevents Western diet-induced obesity and MASH through TGR5. J. Lipid Res. 65, 100527 (2024).","journal-title":"J. Lipid Res."},{"key":"75425_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04367-1","volume":"21","author":"Y Zheng","year":"2023","unstructured":"Zheng, Y., Wang, S., Wu, J. & Wang, Y. Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy. J. Transl. Med. 21, 510 (2023).","journal-title":"J. Transl. Med."},{"key":"75425_CR11","doi-asserted-by":"publisher","unstructured":"Monserrat-Mesquida, M. et al. Oxidative stress and pro-inflammatory status in patients with non-alcoholic fatty liver disease. Antioxidants 9, https:\/\/doi.org\/10.3390\/antiox9080759 (2020).","DOI":"10.3390\/antiox9080759"},{"key":"75425_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-230X-14-81","volume":"14","author":"M Del Ben","year":"2014","unstructured":"Del Ben, M. et al. NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 14, 81 (2014).","journal-title":"BMC Gastroenterol."},{"key":"75425_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41575-024-01014-y","volume":"22","author":"EE Powell","year":"2025","unstructured":"Powell, E. E. A new treatment and updated clinical practice guidelines for MASLD. Nat. Rev. Gastroenterol. Hepatol. 22, 88\u201389 (2025).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"75425_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1053\/j.gastro.2025.07.023","volume":"170","author":"S Lens","year":"2026","unstructured":"Lens, S. Semaglutide in MASH: A promising step forward with room for improvement. Gastroenterology 170, 419\u2013420 (2026).","journal-title":"Gastroenterology"},{"key":"75425_CR15","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nmeth.2033","volume":"9","author":"C Klammt","year":"2012","unstructured":"Klammt, C. et al. Facile backbone structure determination of human membrane proteins by NMR spectroscopy. Nat. Methods 9, 834\u2013839 (2012).","journal-title":"Nat. Methods"},{"key":"75425_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11684-023-1006-x","volume":"18","author":"L Sun","year":"2024","unstructured":"Sun, L. et al. Panoramic variation analysis of a family with neurodevelopmental disorders caused by biallelic loss-of-function variants in TMEM141, DDHD2, and LHFPL5. Front. Med. 18, 81\u201397 (2024).","journal-title":"Front. Med."},{"key":"75425_CR17","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/hep.30631","volume":"70","author":"A Thakur","year":"2019","unstructured":"Thakur, A. et al. Hepatocyte nuclear factor 4-alpha is essential for the active epigenetic state at enhancers in mouse liver. Hepatology 70, 1360\u20131376 (2019).","journal-title":"Hepatology"},{"key":"75425_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8466","volume":"6","author":"Y Xu","year":"2015","unstructured":"Xu, Y. et al. A metabolic stress-inducible miR-34a-HNF4alpha pathway regulates lipid and lipoprotein metabolism. Nat. Commun. 6, 7466 (2015).","journal-title":"Nat. Commun."},{"key":"75425_CR19","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.2337\/db21-0181","volume":"70","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. Hepatocytic activating transcription factor 3 protects against steatohepatitis via hepatocyte nuclear factor 4alpha. Diabetes 70, 2506\u20132517 (2021).","journal-title":"Diabetes"},{"key":"75425_CR20","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1002\/hep.31604","volume":"73","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. Hepatocyte Nuclear Factor 4alpha Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice). Hepatology 73, 2251\u20132265 (2021).","journal-title":"Hepatology"},{"key":"75425_CR21","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.jhep.2021.08.011","volume":"75","author":"T Yang","year":"2021","unstructured":"Yang, T. et al. Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model. J. Hepatol. 75, 1420\u20131433 (2021).","journal-title":"J. Hepatol."},{"key":"75425_CR22","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.tibs.2006.08.002","volume":"31","author":"FY Lee","year":"2006","unstructured":"Lee, F. Y., Lee, H., Hubbert, M. L., Edwards, P. A. & Zhang, Y. FXR, a multipurpose nuclear receptor. Trends Biochem. Sci. 31, 572\u2013580 (2006).","journal-title":"Trends Biochem. Sci."},{"key":"75425_CR23","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1152\/physrev.00049.2019","volume":"101","author":"A Perino","year":"2021","unstructured":"Perino, A., Demagny, H., Velazquez-Villegas, L. & Schoonjans, K. Molecular physiology of bile acid signaling in health, disease, and aging. Physiol. Rev. 101, 683\u2013731 (2021).","journal-title":"Physiol. Rev."},{"key":"75425_CR24","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jhep.2023.07.034","volume":"79","author":"L Adorini","year":"2023","unstructured":"Adorini, L. & Trauner, M. FXR agonists in NASH treatment. J. Hepatol. 79, 1317\u20131331 (2023).","journal-title":"J. Hepatol."},{"key":"75425_CR25","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41401-021-00849-4","volume":"43","author":"SY Tian","year":"2022","unstructured":"Tian, S. Y., Chen, S. M., Pan, C. X. & Li, Y. FXR: structures, biology, and drug development for NASH and fibrosis diseases. Acta Pharm. Sin. 43, 1120\u20131132 (2022).","journal-title":"Acta Pharm. Sin."},{"key":"75425_CR26","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.cmet.2021.05.006","volume":"33","author":"D Huang","year":"2021","unstructured":"Huang, D. et al. TMEM41B acts as an ER scramblase required for lipoprotein biogenesis and lipid homeostasis. Cell Metab. 33, 1655\u20131670 (2021).","journal-title":"Cell Metab."},{"key":"75425_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.102080","volume":"92","author":"A Chhetri","year":"2025","unstructured":"Chhetri, A. et al. TMEM135 deficiency improves hepatic steatosis by suppressing CD36 in a SIRT1-dependent manner. Mol. Metab. 92, 102080 (2025).","journal-title":"Mol. Metab."},{"key":"75425_CR28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien, J., Hayder, H., Zayed, Y. & Peng, C. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front. Endocrinol. 9, 402 (2018).","journal-title":"Front. Endocrinol."},{"key":"75425_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","volume":"79","author":"MR Fabian","year":"2010","unstructured":"Fabian, M. R., Sonenberg, N. & Filipowicz, W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 79, 351\u2013379 (2010).","journal-title":"Annu. Rev. Biochem."},{"key":"75425_CR30","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/hep.26714","volume":"59","author":"J Xu","year":"2014","unstructured":"Xu, J. et al. Hepatic carboxylesterase 1 is essential for both normal and farnesoid X receptor-controlled lipid homeostasis. Hepatology 59, 1761\u20131771 (2014).","journal-title":"Hepatology"},{"key":"75425_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/9780470942390.mo150182","volume":"6","author":"P Jha","year":"2016","unstructured":"Jha, P., Wang, X. & Auwerx, J. Analysis of Mitochondrial Respiratory Chain Supercomplexes Using Blue Native Polyacrylamide Gel Electrophoresis (BN-PAGE). Curr. Protoc. Mouse Biol. 6, 1\u201314 (2016).","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"75425_CR32","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.1021\/bi702243b","volume":"47","author":"D Esterhazy","year":"2008","unstructured":"Esterhazy, D., King, M. S., Yakovlev, G. & Hirst, J. Production of reactive oxygen species by complex I (NADH:ubiquinone oxidoreductase) from Escherichia coli and comparison to the enzyme from mitochondria. Biochemistry 47, 3964\u20133971 (2008).","journal-title":"Biochemistry"},{"key":"75425_CR33","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.freeradbiomed.2010.09.021","volume":"49","author":"G Loor","year":"2010","unstructured":"Loor, G. et al. Menadione triggers cell death through ROS-dependent mechanisms involving PARP activation without requiring apoptosis. Free Radic. Biol. Med. 49, 1925\u20131936 (2010).","journal-title":"Free Radic. Biol. Med."},{"key":"75425_CR34","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.taap.2012.04.030","volume":"262","author":"M Fukui","year":"2012","unstructured":"Fukui, M., Choi, H. J. & Zhu, B. T. Rapid generation of mitochondrial superoxide induces mitochondrion-dependent but caspase-independent cell death in hippocampal neuronal cells that morphologically resembles necroptosis. Toxicol. Appl. Pharm. 262, 156\u2013166 (2012).","journal-title":"Toxicol. Appl. Pharm."},{"key":"75425_CR35","doi-asserted-by":"publisher","first-page":"12419","DOI":"10.1016\/S0021-9258(18)33730-X","volume":"257","author":"H Thor","year":"1982","unstructured":"Thor, H. et al. The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A study of the implications of oxidative stress in intact cells. J. Biol. Chem. 257, 12419\u201312425 (1982).","journal-title":"J. Biol. Chem."},{"key":"75425_CR36","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nrm2256","volume":"8","author":"B D\u2019Autreaux","year":"2007","unstructured":"D\u2019Autreaux, B. & Toledano, M. B. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 8, 813\u2013824 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"75425_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2023.119573","volume":"1871","author":"D Averill-Bates","year":"2024","unstructured":"Averill-Bates, D. Reactive oxygen species and cell signaling. Review. Biochim Biophys. Acta Mol. Cell Res. 1871, 119573 (2024).","journal-title":"Biochim Biophys. Acta Mol. Cell Res."},{"key":"75425_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/B978-0-12-405881-1.00002-1","volume":"528","author":"Y Son","year":"2013","unstructured":"Son, Y., Kim, S., Chung, H. T. & Pae, H. O. Reactive oxygen species in the activation of MAP kinases. Methods Enzymol. 528, 27\u201348 (2013).","journal-title":"Methods Enzymol."},{"key":"75425_CR39","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1089\/ars.2006.8.1775","volume":"8","author":"JA McCubrey","year":"2006","unstructured":"McCubrey, J. A., Lahair, M. M. & Franklin, R. A. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid. Redox Signal 8, 1775\u20131789 (2006).","journal-title":"Antioxid. Redox Signal"},{"key":"75425_CR40","doi-asserted-by":"crossref","unstructured":"Kasai, S., Shimizu, S., Tatara, Y., Mimura, J. & Itoh, K. Regulation of Nrf2 by mitochondrial reactive oxygen species in physiology and pathology. Biomolecules 10, 320(2020).","DOI":"10.3390\/biom10020320"},{"key":"75425_CR41","doi-asserted-by":"crossref","unstructured":"Ngo, V. & Duennwald, M.L. Nrf2 and Oxidative stress: a general overview of mechanisms and implications in human disease. Antioxidants 11, 2345 (2022).","DOI":"10.3390\/antiox11122345"},{"key":"75425_CR42","doi-asserted-by":"crossref","unstructured":"He, F., Ru, X. & Wen, T. NRF2, a Transcription Factor for Stress Response and Beyond. Int. J. Mol. Sci. 21, 4777(2020).","DOI":"10.3390\/ijms21134777"},{"key":"75425_CR43","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/jcb.25074","volume":"116","author":"S Movafagh","year":"2015","unstructured":"Movafagh, S., Crook, S. & Vo, K. Regulation of hypoxia-inducible factor-1a by reactive oxygen species: new developments in an old debate. J. Cell Biochem. 116, 696\u2013703 (2015).","journal-title":"J. Cell Biochem."},{"key":"75425_CR44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","volume":"21","author":"MJ Morgan","year":"2011","unstructured":"Morgan, M. J. & Liu, Z. G. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res. 21, 103\u2013115 (2011).","journal-title":"Cell Res."},{"key":"75425_CR45","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1136\/gut.2008.174904","volume":"59","author":"HY Yue","year":"2010","unstructured":"Yue, H. Y. et al. Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats. Gut 59, 236\u2013246 (2010).","journal-title":"Gut"},{"key":"75425_CR46","doi-asserted-by":"crossref","unstructured":"Pan, X. & Zhang, Y. Hepatocyte nuclear factor 4alpha in the pathogenesis of non-alcoholic fatty liver disease. Chin. Med. J. 135, 1172\u20131181 (2022).","DOI":"10.1097\/CM9.0000000000002092"},{"key":"75425_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116241","volume":"228","author":"C Leahy","year":"2024","unstructured":"Leahy, C. et al. The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review. Biochem. Pharm. 228, 116241 (2024).","journal-title":"Biochem. Pharm."},{"key":"75425_CR48","doi-asserted-by":"publisher","first-page":"16259","DOI":"10.1021\/acsomega.1c01755","volume":"6","author":"H Cui","year":"2021","unstructured":"Cui, H., Zhu, X., Li, S., Wang, P. & Fang, J. Liver-targeted delivery of oligonucleotides with N-acetylgalactosamine conjugation. ACS Omega 6, 16259\u201316265 (2021).","journal-title":"ACS Omega"},{"key":"75425_CR49","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1161\/ATVBAHA.121.316290","volume":"41","author":"EAL Biessen","year":"2021","unstructured":"Biessen, E. A. L. & Van Berkel, T. J. C. N-Acetyl galactosamine targeting: paving the way for clinical application of nucleotide medicines in cardiovascular diseases. Arterioscler. Thromb. Vasc. Biol. 41, 2855\u20132865 (2021).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"75425_CR50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1089\/nat.2018.0736","volume":"28","author":"AD Springer","year":"2018","unstructured":"Springer, A. D. & Dowdy, S. F. GalNAc-siRNA Conjugates: leading the way for delivery of RNAi therapeutics. Nucleic Acid Ther. 28, 109\u2013118 (2018).","journal-title":"Nucleic Acid Ther."},{"key":"75425_CR51","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cmet.2024.03.003","volume":"36","author":"L Tong","year":"2024","unstructured":"Tong, L. et al. Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity. Cell Metab. 36, 1013\u20131029 e1015 (2024).","journal-title":"Cell Metab."},{"key":"75425_CR52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/jcph.2337","volume":"64","author":"G An","year":"2024","unstructured":"An, G. Pharmacokinetics and pharmacodynamics of GalNAc-conjugated siRNAs. J. Clin. Pharm. 64, 45\u201357 (2024).","journal-title":"J. Clin. Pharm."},{"key":"75425_CR53","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev-biochem-070511-103700","volume":"82","author":"J Hirst","year":"2013","unstructured":"Hirst, J. Mitochondrial complex I. Annu. Rev. Biochem. 82, 551\u2013575 (2013).","journal-title":"Annu. Rev. Biochem."},{"key":"75425_CR54","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1172\/JCI73137","volume":"125","author":"T Nishikawa","year":"2015","unstructured":"Nishikawa, T. et al. Resetting the transcription factor network reverses terminal chronic hepatic failure. J. Clin. Invest 125, 1533\u20131544 (2015).","journal-title":"J. Clin. Invest"},{"key":"75425_CR55","doi-asserted-by":"publisher","first-page":"16483","DOI":"10.1074\/jbc.270.28.16483","volume":"270","author":"M Karin","year":"1995","unstructured":"Karin, M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 16483\u201316486 (1995).","journal-title":"J. Biol. Chem."},{"key":"75425_CR56","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1194\/jlr.M088880","volume":"60","author":"KJ Won","year":"2019","unstructured":"Won, K. J., Park, J. S. & Jeong, H. Repression of hepatocyte nuclear factor 4 alpha by AP-1 underlies dyslipidemia associated with retinoic acid. J. Lipid Res. 60, 794\u2013804 (2019).","journal-title":"J. Lipid Res."},{"key":"75425_CR57","doi-asserted-by":"publisher","first-page":"108777","DOI":"10.1016\/j.jdiacomp.2024.108777","volume":"38","author":"SG Albert","year":"2024","unstructured":"Albert, S. G. & Wood, E. M. FIB-4 as a screening and disease monitoring method in pre-fibrotic stages of metabolic dysfunction-associated fatty liver disease (MASLD). J. Diab. Complications 38, 108777 (2024).","journal-title":"J. Diab. Complications"},{"key":"75425_CR58","first-page":"641","volume":"15","author":"T Pacana","year":"2012","unstructured":"Pacana, T. & Sanyal, A. J. Vitamin E and nonalcoholic fatty liver disease. Curr. Opin. Clin. Nutr. Metab. Care 15, 641\u2013648 (2012).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"75425_CR59","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/jcmm.17649","volume":"27","author":"VJ Thannickal","year":"2023","unstructured":"Thannickal, V. J., Jandeleit-Dahm, K., Szyndralewiez, C. & Torok, N. J. Pre-clinical evidence of a dual NADPH oxidase 1\/4 inhibitor (setanaxib) in liver, kidney and lung fibrosis. J. Cell Mol. Med. 27, 471\u2013481 (2023).","journal-title":"J. Cell Mol. Med."},{"key":"75425_CR60","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/jn\/138.10.1872","volume":"138","author":"JN Baumgardner","year":"2008","unstructured":"Baumgardner, J. N. et al. N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis. J. Nutr. 138, 1872\u20131879 (2008).","journal-title":"J. Nutr."},{"key":"75425_CR61","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/jpn3.12312","volume":"79","author":"P Babu Balagopal","year":"2024","unstructured":"Babu Balagopal, P. et al. Effect of N-acetyl cysteine in children with metabolic dysfunction-associated steatotic liver disease-A pilot study. J. Pediatr. Gastroenterol. Nutr. 79, 652\u2013660 (2024).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"75425_CR62","doi-asserted-by":"publisher","unstructured":"Hong, Y., Boiti, A., Vallone, D. & Foulkes, N.S. Reactive oxygen species signaling and oxidative stress: transcriptional regulation and evolution. Antioxidants 13, https:\/\/doi.org\/10.3390\/antiox13030312 (2024).","DOI":"10.3390\/antiox13030312"},{"key":"75425_CR63","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","volume":"24","author":"PD Ray","year":"2012","unstructured":"Ray, P. D., Huang, B. W. & Tsuji, Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24, 981\u2013990 (2012).","journal-title":"Cell Signal"},{"key":"75425_CR64","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","volume":"13","author":"N Stefan","year":"2025","unstructured":"Stefan, N., Yki-Jarvinen, H. & Neuschwander-Tetri, B. A. Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment. Lancet Diab. Endocrinol. 13, 134\u2013148 (2025).","journal-title":"Lancet Diab. Endocrinol."},{"key":"75425_CR65","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison, S. A. et al. A Phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N. Engl. J. Med. 390, 497\u2013509 (2024).","journal-title":"N. Engl. J. Med."},{"key":"75425_CR66","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.tips.2024.08.009","volume":"45","author":"NF Brisnovali","year":"2024","unstructured":"Brisnovali, N. F., Haney, C. & Goedeke, L. Rezdiffra (resmetirom): a THR-beta agonist for non-alcoholic steatohepatitis. Trends Pharm. Sci. 45, 1081\u20131082 (2024).","journal-title":"Trends Pharm. Sci."},{"key":"75425_CR67","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1016\/j.ymthe.2026.04.011","volume":"34","author":"M Liu","year":"2026","unstructured":"Liu, M., Ma, Y., San Cheang, W., Su, Z. & Xu, S. A new liver-targeted agonist of thyroid hormone receptor beta resmetirom in treating MASLD\/MASH: From mechanism to therapy. Mol. Ther. 34, 3192\u20133216 (2026).","journal-title":"Mol. Ther."},{"key":"75425_CR68","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1111\/jgh.17037","volume":"40","author":"D Ezhilarasan","year":"2025","unstructured":"Ezhilarasan, D. Mechanism of semaglutide in MASLD treatment: where is the master key? J. Gastroenterol. Hepatol. 40, 2163\u20132175 (2025).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"75425_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155909","volume":"155","author":"X Pan","year":"2024","unstructured":"Pan, X. et al. Kruppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4alpha-mediated metabolic pathways. Metabolism 155, 155909 (2024).","journal-title":"Metabolism"},{"key":"75425_CR70","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s42255-020-00331-1","volume":"3","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism. Nat. Metab. 3, 59\u201374 (2021).","journal-title":"Nat. Metab."},{"key":"75425_CR71","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1161\/ATVBAHA.110.217828","volume":"31","author":"L Yin","year":"2011","unstructured":"Yin, L., Ma, H., Ge, X., Edwards, P. A. & Zhang, Y. Hepatic hepatocyte nuclear factor 4alpha is essential for maintaining triglyceride and cholesterol homeostasis. Arterioscler Thromb. Vasc. Biol. 31, 328\u2013336 (2011).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"75425_CR72","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1101\/gad.1138104","volume":"18","author":"Y Zhang","year":"2004","unstructured":"Zhang, Y., Castellani, L. W., Sinal, C. J., Gonzalez, F. J. & Edwards, P. A. Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev. 18, 157\u2013169 (2004).","journal-title":"Genes Dev."},{"key":"75425_CR73","doi-asserted-by":"publisher","unstructured":"Wang, H. et al. Loss of hepatocyte FOXA3 improves MASH and atherosclerosis in hyperlipidemic Ldlr-deficient mice. Int. J. Mol. Sci. 27, https:\/\/doi.org\/10.3390\/ijms27031468 (2026).","DOI":"10.3390\/ijms27031468"},{"key":"75425_CR74","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u20131321 (2005).","journal-title":"Hepatology"},{"key":"75425_CR75","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.yjmcc.2018.07.244","volume":"121","author":"PT Kang","year":"2018","unstructured":"Kang, P. T. et al. Mitochondrial complex I in the post-ischemic heart: reperfusion-mediated oxidative injury and protein cysteine sulfonation. J. Mol. Cell Cardiol. 121, 190\u2013204 (2018).","journal-title":"J. Mol. Cell Cardiol."},{"key":"75425_CR76","doi-asserted-by":"publisher","first-page":"13939","DOI":"10.1073\/pnas.0907143106","volume":"106","author":"E Sanz","year":"2009","unstructured":"Sanz, E. et al. Cell-type-specific isolation of ribosome-associated mRNA from complex tissues. Proc. Natl. Acad. Sci. USA. 106, 13939\u201313944 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75425_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2024.102842","volume":"5","author":"B Ramatchandirin","year":"2024","unstructured":"Ramatchandirin, B. et al. Protocol for measuring mitochondrial size in mouse and human liver tissues. STAR Protoc. 5, 102842 (2024).","journal-title":"STAR Protoc."},{"key":"75425_CR78","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1172\/JCI95802","volume":"128","author":"SH Jeong","year":"2018","unstructured":"Jeong, S. H. et al. Hippo-mediated suppression of IRS2\/AKT signaling prevents hepatic steatosis and liver cancer. J. Clin. Invest. 128, 1010\u20131025 (2018).","journal-title":"J. Clin. Invest."},{"key":"75425_CR79","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neurobiolaging.2022.08.007","volume":"120","author":"AM Mafi","year":"2022","unstructured":"Mafi, A. M., Tokar, N., Russ, M. G., Barat, O. & Mellott, J. G. Age-related ultrastructural changes in the lateral cortex of the inferior colliculus. Neurobiol. Aging 120, 43\u201359 (2022).","journal-title":"Neurobiol. Aging"},{"key":"75425_CR80","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nature19794","volume":"538","author":"K Fiedorczuk","year":"2016","unstructured":"Fiedorczuk, K. et al. Atomic structure of the entire mammalian mitochondrial complex I. Nature 538, 406\u2013410 (2016).","journal-title":"Nature"},{"key":"75425_CR81","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","volume":"15","author":"Y Yan","year":"2020","unstructured":"Yan, Y., Tao, H., He, J. & Huang, S. Y. The HDOCK server for integrated protein-protein docking. Nat. Protoc. 15, 1829\u20131852 (2020).","journal-title":"Nat. Protoc."},{"key":"75425_CR82","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/bioinformatics\/btu097","volume":"30","author":"BG Pierce","year":"2014","unstructured":"Pierce, B. G. et al. ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers. Bioinformatics 30, 1771\u20131773 (2014).","journal-title":"Bioinformatics"},{"key":"75425_CR83","doi-asserted-by":"publisher","first-page":"H1410","DOI":"10.1152\/ajpheart.00731.2011","volume":"302","author":"HL Lee","year":"2012","unstructured":"Lee, H. L., Chen, C. L., Yeh, S. T., Zweier, J. L. & Chen, Y. R. Biphasic modulation of the mitochondrial electron transport chain in myocardial ischemia and reperfusion. Am. J. Physiol. Heart Circ. Physiol. 302, H1410\u2013H1422 (2012).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"75425_CR84","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00395-017-0626-1","volume":"112","author":"PT Kang","year":"2017","unstructured":"Kang, P. T., Chen, C. L., Lin, P., Chilian, W. M. & Chen, Y. R. Impairment of pH gradient and membrane potential mediates redox dysfunction in the mitochondria of the post-ischemic heart. Basic Res. Cardiol. 112, 36 (2017).","journal-title":"Basic Res. Cardiol."},{"key":"75425_CR85","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1016\/j.cell.2022.10.003","volume":"185","author":"H Xiao","year":"2022","unstructured":"Xiao, H. et al. Architecture of the outbred brown fat proteome defines regulators of metabolic physiology. Cell 185, 4654\u20134673 (2022).","journal-title":"Cell"},{"key":"75425_CR86","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-1-0716-2128-8_6","volume":"2455","author":"SS Ghosh","year":"2022","unstructured":"Ghosh, S. S., Wang, J. & Ghosh, S. Measurement of in vivo VLDL and chylomicron secretion. Methods Mol. Biol. 2455, 63\u201371 (2022).","journal-title":"Methods Mol. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75425-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75425-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75425-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:03:05Z","timestamp":1787097785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75425-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75425"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75425-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8582"}}